Transarterial chemoembolization of metastatic colorectal carcinoma with drug-eluting beads, irinotecan (DEBIRI): Multi-institutional registry

Journal of Oncology

Volumn , Issue , 2009, Pages

  Martin, Robert C G ^a   Joshi, Jonathan ^a   Robbins, Ken ^b   Tomalty, Dana ^c   O'Hara, Ryan ^d   Tatum, Cliff ^e  

^a University of Louisville School of Medicine   (United States)

^b Baptist Health Arkansas   (United States)

^c HUNTSVILLE HOSPITAL   (United States)

^d Radiology and Imaging Consultants   (United States)

^e Norton Healthcare   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CAPECITABINE; CETUXIMAB; CIPROFLOXACIN; DEBIRI; DEXAMETHASONE; FLUOROURACIL; FOLINIC ACID; HYDROCODONE BITARTRATE PLUS IBUPROFEN; IRINOTECAN; KEFSOL; KETOROLAC; LEVOFLOXACIN; METRONIDAZOLE; MICROSPHERE; ONDANSETRON; OXALIPLATIN; PROCHLORPERAZINE MALEATE; PROMETHAZINE; PROTON PUMP INHIBITOR; UNCLASSIFIED DRUG; VECTIBEX;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CHEMOEMBOLIZATION; CHEMOTHERAPY INDUCED EMESIS; CHOLECYSTITIS; CLINICAL ARTICLE; CLINICAL EVALUATION; COLORECTAL CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEHYDRATION; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; GASTRITIS; HUMAN; HYPERTENSION; INFECTION; LIVER ANGIOGRAPHY; LIVER DYSFUNCTION; LIVER FAILURE; LIVER METASTASIS; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; PAIN; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PROSPECTIVE STUDY; SINGLE DRUG DOSE; TRANSARTERIAL CHEMOEMBOLIZATION; TREATMENT RESPONSE; TUMOR VOLUME; VOMITING;

EID: 71149097101     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2009/539795     Document Type: Article

References (21)

1. Sjvall A., Jrv V., Blomqvist L., The potential for improved outcome in patients with hepatic metastases from colon cancer: a population-based study European Journal of Surgical Oncology 2004 30 8 834 841
2. Scoggins C. R., Campbell M. L., Landry C. S., Preoperative chemotherapy does not increase morbidity or mortality of hepatic resection for colorectal cancer metastases Annals of Surgical Oncology 2009 16 1 35 41
3. Reuter N. P., Woodall C. E., Scoggins C. R., McMasters K. M., Martin R. C. G., Radiofrequency ablation vs. resection for hepatic colorectal metastasis: therapeutically equivalent? Journal of Gastrointestinal Surgery 2009 13 3 486 491
4. Brown D. B., Gould J. E., Gervais D. A., Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria Journal of Vascular and Interventional Radiology 2007 18 12 1469 1478
5. Aliberti C., Tilli M., Benea G., Fiorentini G., Trans-arterial chemoembolization (TACE) of liver metastases from colorectal cancer using irinotecan-eluting beads: preliminary results Anticancer Research 2006 26 5 3793 3795
6. Fiorentini G., Aliberti C., Turrisi G., Intraarterial hepatic chemoembolization of liver metastases from colorectal cancer adopting irinotecan-eluting beads: results of a phase II clinical study In Vivo 2007 21 6 1085 1092
7. Saltz L. B., Cox J. V., Blanke C., Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group The New England Journal of Medicine 2000 343 13 905 914
8. Goldberg R. M., Sargent D. J., Morton R. F., A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer Journal of Clinical Oncology 2004 22 1 23 30
9. Rothenberg M. L., Oza A. M., Bigelow R. H., Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial Journal of Clinical Oncology 2003 21 11 2059 2069
10. Chen H. X., Mooney M., Boron M., Phase II multicenter trial of bevacizumab plus fluorouracil and leucovorin in patients with advanced refractory colorectal cancer: an NCI treatment referral center trial TRC-0301 Journal of Clinical Oncology 2006 24 21 3354 3360
11. Therasse P., Arbuck S. G., Eisenhauer E. A., New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada Journal of the National Cancer Institute 2000 92 3 205 216
12. Bruix J., Sherman M., Llovet J. M., Clinical management of hepatocellular carcinoma. Conclusions of the barcelona-2000 EASL conference. European Association for the Study of the Liver Journal of Hepatology 2001 35 3 421 430
13. Choi H., Charnsangavej C., Faria S. C., Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria Journal of Clinical Oncology 2007 25 13 1753 1759
14. Kemeny N., Daly J., Reichman B., Geller N., Botet J., Oderman P., Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial Annals of Internal Medicine 1987 107 4 459 465 (Pubitemid 17149758)
15. Brown D. B., Geschwind J.-F. H., Soulen M. C., Millward S. F., Sacks D., Society of interventional radiology position statement on chemoembolization of hepatic malignancies Journal of Vascular and Interventional Radiology 2006 17 2 217 223
16. Herrmann K. A., Waggershauser T., Sittek H., Reiser M. F., Liver intraarterial chemotherapy: use of the femoral artery for percutaneous implantation of catheter-port systems Radiology 2000 215 1 294 299
17. Kemeny M. M., Adak S., Gray B., Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapyan intergroup study Journal of Clinical Oncology 2002 20 6 1499 1505
18. Martin R. C., Edwards M. J., McMasters K. M., Morbidity of adjuvant hepatic arterial infusion pump chemotherapy in the management of colorectal cancer metastatic to the liver American Journal of Surgery 2004 188 6 714 721
19. Herrmann K. A., Waggershauser T., Sittek H., Reiser M. F., Liver intraarterial chemotherapy: use of the femoral artery for percutaneous implantation of catheter-port systems Radiology 2000 215 1 294 299
20. Tang Y., Taylor R. R., Gonzalez M. V., Lewis A. L., Stratford P. W., Evaluation of irinotecan drug-eluting beads: a new drug-device combination product for the chemoembolization of hepatic metastases Journal of Controlled Release 2006 116 2 e55 e56
21. Taylor R. R., Tang Y., Gonzalez M. V., Stratford P. W., Lewis A. L., Irinotecan drug eluting beads for use in chemoembolization: in vitro and in vivo evaluation of drug release properties European Journal of Pharmaceutical Sciences 2007 30 1 7 14